BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715
289 results:

  • 1. Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of cebpa and FOXA1 in liver cancer cells.
    Nakagawa S; Yamaguchi K; Takane K; Tabata S; Ikenoue T; Furukawa Y
    Commun Biol; 2024 Apr; 7(1):510. PubMed ID: 38684876
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction-associated steatohepatitis.
    Steffani M; Geng Y; Pajvani UB; Schwabe RF
    J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557494
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.
    Yan T; Yan N; Xia Y; Sawaswong V; Zhu X; Dias HB; Aibara D; Takahashi S; Hamada K; Saito Y; Li G; Liu H; Yan H; Velenosi TJ; Krausz KW; Huang J; Kimura S; Rotman Y; Qu A; Hao H; Gonzalez FJ
    J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557493
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Knowledge, attitude, and practice toward weight management among diabetic patients in Qidong City, Jiangsu Province.
    Li X; Shi Y; Wei D; Gong Y; Yan X; Cai S
    BMC Public Health; 2024 Mar; 24(1):922. PubMed ID: 38553699
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
    Jantaravinid J; Tirawanchai N; Ampawong S; Kengkoom K; Somkasetrin A; Nakhonsri V; Aramwit P
    Sci Rep; 2024 Mar; 14(1):5455. PubMed ID: 38443583
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma.
    Ishteyaque S; Yadav KS; Verma S; Washimkar KR; Mugale MN
    Arch Biochem Biophys; 2023 Sep; 745():109701. PubMed ID: 37499993
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.
    He L; Li H; Li C; Liu ZK; Lu M; Zhang RY; Wu D; Wei D; Shao J; Liu M; Wei HL; Zhang C; Wang Z; Kong LM; Chen ZN; Bian H
    Cancer Commun (Lond); 2023 Sep; 43(9):981-1002. PubMed ID: 37405956
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma.
    Wang Y; Hu P; Wang F; Xi S; Wu S; Sun L; Du Y; Zheng J; Yang H; Tang M; Gao H; Luo H; Lv Y; Yan J; Ou X; Li Y
    Cell Death Dis; 2023 Jun; 14(6):381. PubMed ID: 37380646
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Advances in the genetics of nonalcoholic fatty liver disease.
    Ajmera V; Loomba R
    Curr Opin Gastroenterol; 2023 May; 39(3):150-155. PubMed ID: 37144531
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LncRNA cebpa-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
    Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
    J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Renoportal Anastomosis and Its Complications: A Complex Case Report.
    Perfecto A; Gastaca M; Prieto M; Palomares I; Ventoso A; Ruiz P; Mambrilla S; Muga E; Senosiain M; Salvador P; Testillano M; Fernández JR; Bustamante FJ; Valdivieso A
    Transplant Proc; 2022 Nov; 54(9):2552-2555. PubMed ID: 36328817
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lutein ameliorates high-fat diet-induced obesity, fatty liver, and glucose intolerance in C57BL/6J mice.
    Gopal SS; Sukhdeo SV; Vallikannan B; Ponesakki G
    Phytother Res; 2023 Jan; 37(1):329-341. PubMed ID: 36086831
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Low-density cell culture enhances hepatic function through tight junction formation in HepG2 cells.
    Tanaka-Yachi R; Aizawa K; Shimizu K; Akutsu H; Nakamura K
    Biol Cell; 2022 Sep; 114(9):225-236. PubMed ID: 35603978
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dynamic network biomarker analysis and system pharmacology methods to explore the therapeutic effects and targets of Xiaoyaosan against liver cirrhosis.
    Lu Y; Li M; Zhou Q; Fang D; Wu R; Li Q; Chen L; Su S
    J Ethnopharmacol; 2022 Aug; 294():115324. PubMed ID: 35489663
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study.
    Etemadi A; Hariri S; Hassanian-Moghaddam H; Poustchi H; Roshandel G; Shayanrad A; Kamangar F; Boffetta P; Brennan P; Dargan PI; Dawsey SM; Jones RL; Freedman ND; Malekzadeh R; Abnet CC
    Int J Drug Policy; 2022 Jun; 104():103695. PubMed ID: 35472727
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.
    Kefayat A; Hosseini M; Ghahremani F; Jolfaie NA; Rafienia M
    J Nanobiotechnology; 2022 Mar; 20(1):169. PubMed ID: 35361226
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.
    Ji GW; Jiao CY; Xu ZG; Li XC; Wang K; Wang XH
    BMC Cancer; 2022 Mar; 22(1):258. PubMed ID: 35277130
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Carcinogens in Food: Evaluating the Presence of Cadmium, Lead, in Poultry Meat in South India.
    Pappuswamy M; Meyyazhagan A; Balasubramanian B; Bhotla HK; Pushparaj K; Easwaran M; Arumugam VA; Periyaswamy T; Dhandapani K
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3507-3511. PubMed ID: 34837906
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nucleolar protein 6 promotes cell proliferation and acts as a potential novel prognostic marker for hepatocellular carcinoma.
    Meng L; Xu KX; Zhao MX; Li K; Zhu K; Yuan DW; Wang HN; Dai PG; Yan R
    Chin Med J (Engl); 2021 Sep; 134(21):2611-2618. PubMed ID: 34561331
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with cancer.
    Hashimoto A; Sarker D; Reebye V; Jarvis S; Sodergren MH; Kossenkov A; Sanseviero E; Raulf N; Vasara J; Andrikakou P; Meyer T; Huang KW; Plummer R; Chee CE; Spalding D; Pai M; Khan S; Pinato DJ; Sharma R; Basu B; Palmer D; Ma YT; Evans J; Habib R; Martirosyan A; Elasri N; Reynaud A; Rossi JJ; Cobbold M; Habib NA; Gabrilovich DI
    Clin Cancer Res; 2021 Nov; 27(21):5961-5978. PubMed ID: 34407972
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.